The case of a man with Fabry disease that co-occurred with a rare autoimmune kidney disorder was described in…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
Note: This story was updated Jan. 17, 2022, to note that Avrobio is deprioritizing its Fabry program. …
A man living with Fabry disease for more than two decades was found to have a second co-occurring genetic…
Protalix BioTherapeutics has requested a type A meeting with the U.S. Food and Drug Administration (FDA) to discuss a…
Family genetic testing can help to diagnose people with rare genetic conditions like Fabry disease, but there still are…
A new infusion protocol that gradually reduces the amount of time needed for the delivery of the Fabry disease…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Enzyme replacement therapy (ERT) may not effectively manage all aspects of Fabry disease in all patients, particularly when started…
Cysts in the kidneys are more common in people with Fabry disease than in other diseases that affect the…